Karolinska Institutet and Massachusetts General Hospital have concluded a study that brings a new insight into the difficult treatment of fibromyalgia.
This new study, corroborated by other researchers, suggests that the central nervous system’s immune cells are activated in patients with fibromyalgia and that the degree of activation is directly proportional with the level of fatigue the patients manifest. This implies a direct link between the aberrations of the brain and fibromyalgia symptoms.
Eva Kosek who conducted the study at the Karolinska Institutet, shares on the Institute’s website:
“The findings may open the way for the development of completely new therapies for this currently difficult-to-treat condition,” says Professor Kosek. “The fact that scientific research is able to demonstrate objective aberrations in the brains of people with fibromyalgia will hopefully mitigate the suspicion with which patients are often treated by the health services and society.”
The study “Brain glial activation in fibromyalgia – A multi-site positron emission tomography investigation” is published on the Science Direct website.